IL6 and cancer: In addition, IL-17 in T-ALL also induces the production of different inflammatory cytokines such as IL-6, TNF-α and prostaglandins, which further favours the progression of the disease by endowing stemness and self-renewal in cancer cells, allowing them to evade immune response, and acquire chemoresistance (Ankathatti Munegowda et al., 2011).